Convicted Harvard Scientist Rebuilds High-Tech Brain Lab in China

A former Harvard University scientist convicted in the United States has resurfaced in China, where he is now leading a major state-backed brain-computer interface research initiative, raising fresh concerns about global technology competition and security.

Charles Lieber, once a prominent nanotechnology researcher at Harvard University, has established a new laboratory in Shenzhen focused on embedding electronic systems into the human brain. The project is part of China’s growing investment in advanced neurotechnology, a field with both medical and military applications.

Lieber was convicted in 2021 for making false statements to U.S. authorities regarding his ties to a Chinese talent recruitment programme, as well as for tax-related offences. He served a short prison sentence and home confinement before later relocating to China.

Now 67, he is playing a leading role in China’s state-funded i-BRAIN programme under the Shenzhen Medical Academy of Research and Translation (SMART). Reports indicate that his new lab is equipped with advanced nanofabrication tools and access to primate research facilities; resources that surpass what he previously had access to in the United States.

The research focuses on brain-computer interface (BCI) technology, which scientists say could revolutionize treatment for neurological conditions such as paralysis and ALS. However, the same technology has drawn scrutiny due to its potential military uses, including enhancing cognitive performance in soldiers.

Analysts warn that Lieber’s move underscores broader challenges facing U.S. efforts to control the transfer of sensitive technologies. Despite legal action against him, his ability to rebuild a high-level research operation abroad highlights what some experts see as gaps in enforcement and global scientific competition.

China has identified brain-computer interfaces as a strategic priority in its long-term technological development plans, investing heavily in research and talent recruitment as part of its ambition to lead in next-generation innovation.

The development is likely to intensify concerns in Washington over the movement of expertise and intellectual property, especially in fields where civilian research can have dual-use military implications.